Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device zaps wrinkles without surgery – but does it work?

NCT ID NCT07585591

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the XERF device, which uses radiofrequency energy to tighten skin and reduce wrinkles on the face and neck. Forty healthy adults received up to three treatments. Researchers measured improvement using doctor ratings and patient satisfaction. The goal was to see if the device is safe and effective for cosmetic use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
XERF noninvasive dual-frequency monopolar radiofrequency device
What this could lead to
If successful, this device could offer a non-surgical option for tightening skin and reducing wrinkles on the face and neck.
What could go wrong
This is a small, completed trial with no control group, so results may not apply to everyone. The device may cause temporary discomfort or side effects like redness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jan 2025

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 22 - 70 years old * Is willing to undergo study device use. * Has not received any toxin/filler in the treatment area in the past 6 months and agrees to not receive any throughout the study. * Willing to maintain current diet and exercise routine throughout study duration. * Understands and accepts the study condition to not receive any other procedures to the treatment area or to undergo any procedures, take any medications, supplements, or partake in any treatments indicated for weight loss or body contouring throughout the length of the study. * Understands and accepts the study condition of and agrees that he or she is able to be present for all study visits. * Willing to comply with all requirements of the study and is able to provide written informed consent. Exclusion Criteria: * Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding, or planning a pregnancy during the study period. * Has an implanted pacemaker, internal ventricular fibrillation controller (AICD), or any electrical device. * Has a metal implant that interferes with the transmission of energy to the electrical field. * Has received permanent fillers or facial implants. * Has a detected pathological abnormality. * Has a medical condition with potentially decreased function of the peripheral nervous tissue, such as but not limited to diabetes or multiple sclerosis. * Has an infection or infected tissue in the treatment area. * Unable or not willing to follow instructions for pre- and post-treatment care * Recent history of smoking (1 month) * Has unrealistic treatment expectations. * Has a history of herpes simplex in which the patient is not willing/able to receive preventive antiviral therapy. * Has a blood disorder and taking aspirin or blood disorder medications. * Has a malignant disease, cancer, or uncontrolled autoimmune disease. * Had previous surgical or cosmetic procedures in the treatment area in the last 3 months that could interfere with the treatment procedure (including but not limited to dermabrasion, chemical peels, laser skin resurfacing, fat augmentations, topical retinoids and radiofrequency treatments) * Currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within the area to be treated 6 months prior to entering this study * Has any condition or is in a situation which, in the investigator's opinion, may put the subject at significant risk, may confound study results, or may interfere significantly with the subject's participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Laser & Skin Surgery Center of Pennsylvania

    Devon, Pennsylvania, 19333, United States

  • Maryland Dermatology Laser, Skin, & Vein Institute, LLC

    Hunt Valley, Maryland, 21030, United States

  • New Jersey Plastic Surgery

    Montclair, New Jersey, 07042, United States

  • Oak Dermatology

    Naperville, Illinois, 60563, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.